We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Stealth BioTherapeutics filed on Friday to raise up to $86 million in its Nasdaq IPO, funding that will push its lead asset through the clinic in multiple indications......